The bill, sponsored by Sen. Mike McGuire, D-xx, would bar drug companies “from providing flights, travel, speaking fees, consulting payments, entertainment or other economic benefits to healthcare providers,” according to a news release on Mr. McGuire’s website.
Drugmakers spend more than $1.4 billion annually on these perks for California clinicians, according to Mr. McGuire. He believes the bill would help lower drug costs, since physicians who receive the gifts are more likely to prescribe the expensive brand name drugs, reports San Antonio Express-News.
The Senate advanced the bill, which is modeled after a similar Vermont law enacted in 2009, to the state Assembly, according to the report.
More articles on supply chain:
Top 5 retail pharmacy chains by store count
4 latest FDA approvals
Supply chain tip of the day: Reducing supply fee structures
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
